Allarity Therapeutics, Inc. 8-K

What Happened Allarity Therapeutics, Inc. announced on April 21, 2026 that two scientific posters from the company are being presented at the American Association for Cancer Research (AACR) Annual Meeting 2026, held April 17–22, 2026 in San Diego, California. The company filed a press release about the presentations as Exhibit 99.1 to its Form 8‑K (filed April 22, 2026).

Key Details

• Announcement date: April 21, 2026; Form 8‑K filed April 22, 2026.
• Event: AACR Annual Meeting 2026, San Diego, April 17–22, 2026.
• Number of posters: two scientific posters presented by the company.
• Press release announcing the posters is included as Exhibit 99.1 to the 8‑K.

Why It Matters Scientific presentations at major conferences like AACR can increase visibility for Allarity’s research programs and provide peer exposure for preclinical or clinical data. For investors, this filing signals ongoing R&D activity and outreach to the scientific community; the 8‑K itself does not disclose detailed data or any direct financial impact. Continue to watch company releases or the posted abstracts for substantive clinical or study results.